삼성에피스홀딩스

0126Z0KOSPI기타 금융업

50.4 / 100

Reference Date: 2026-06-10

Financial Score15.0 / 40

News Sentiment19.4 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Plunged 20.0% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Samsung Epis Holdings is a biotech investment holding company with two subsidiaries, Samsung Bioepis and Epis Nex Lab. Samsung Bioepis focuses on commercializing 11 biosimilar products, contributing 96.7% of 2025 revenue, and is expanding into ADC drug development. Epis Nex Lab, established in 2025, is focused on next-generation biotech platforms but has not yet generated revenue.

Number of Employees

18people

Average Salary

—

Score Calculation Basis

Detailed Financial Score

PER

122.63Industry Average 9.680.0Point

12.7x industry avg (risky)

PBR

1.77Industry Average 0.460.0Point

3.8x industry avg (risky)

ROE

—Industry Average 5.413.5Point

Debt Ratio

6.92Industry Average 16.696.5Point

Half of industry avg (excellent)

Trend 5.0 / 10 points

Revenue Growth Rate

1.5 / 3

Operating Profit Growth Rate

1.5 / 3

ROE Trend

2.0 / 4

Detailed News Sentiment

22 totalPositive 17Neutral 3Negative 2Average Sentiment Score 77.7

Positive
폭락장 비껴간 대원제약…비만신약 기대감에 19% 상승 [Why 바이오]
대원제약의 비만신약 기대감으로 인해 주가가 19% 상승했다.
Neutral
[ESG 점검] 삼성에피스홀딩스, 통합보고 첫발…CMO·품질 지표 과제
삼성에피스홀딩스의 첫 통합 지속가능경영보고서 발표로 ESG 관리 체계 개선이 강조되었으나, 정량적 성과는 아직 미흡하다.
Positive
'2000억 베팅' 삼성 바이오펀드 3호, 로직스·에피스 병목 겨냥
삼성바이오로직스와 삼성바이오에피스의 성장 과제 해결을 위한 대규모 투자 확대로 긍정적 영향 기대.

Detailed Momentum

52-week position3.0Point

52w lower range (20%)

Current 421,000Won52-week high 743,00052-week low 335,500

1-month return0.0Point

1m -19.96% (strong drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

9 totalPositive 0Neutral 9Negative 0

Neutral최대주주등소유주식변동신고서2026-06-08
Neutral[기재정정]대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]2026-06-01
Neutral기업지배구조보고서공시2026-06-01
Neutral대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]2026-06-01
Neutral단기차입금증가결정(자회사의 주요경영사항)2026-05-28